CNXU: Net loss surged as operating costs rose post-Nasdaq listing, with urgent need for new financing

Turn Therapeutics (TTRX) rose over 20% after interim Phase 2 results for GX-03 in atopic dermatitis, with 92.6% achieving EASI-50 at 4 weeks. Conexeu (CNXU) gained ~19% on preclinical B.R.E.A.S.T. bioprinting progress. Rallybio (RLYB) jumped on plans to acquire Avenzo via a $215M investment. LIXTE (LIXT) surged on an AI energy pivot; Quanterix (QTRX) rose on insider SEC filing.

Conexeu Sciences (Nasdaq: CNXU) said it has started a preclinical development program for its B.R.E.A.S.T.™ 3D-printed bioregenerative breast matrix at the Wake Forest Institute for Regenerative Medicine (WFIRM). The study will assess durability, host tissue integration and resorbability of its CXU™ matrix platform, using WFIRM’s bioprinting infrastructure.

Tesco Plc reported a 11.5% increase in H1 profit before tax to £1.455 billion, with revenue up 3.7% to £37.353 billion. EPS rose 17.4% to 16.7 pence. The company raised its FY27 profit outlook to £3.15-3.30 billion and increased its share buyback program to £950 million. An interim dividend of 5.05 pence per share was announced.

Samsung 005930 forecasted a 783% year-over-year increase in quarterly operating profit to $80 billion, driven by AI memory demand. Revenue is expected to rise 126.6% to 195 trillion won. Despite strong earnings, shares slipped 0.2% in early trading, reflecting investor caution about the sustainability of the boom.

Value Line (NASDAQ: VALU) reported earnings growth and extended its dividend growth streak to 12 years. The company reduced costs through outsourcing and digital delivery, though paper and postage costs remain challenges. Shareholders elected new directors, and CEO Howard Brecher noted the company's resilience to economic factors like tariffs and oil-supply disruptions. The U.S. economy was described as stable, with rising prices and interest rates.

TSMC reported September revenue of NT$511.86 billion ($16.03 billion), up 54.6% year-over-year, driven by AI chip demand. The stock fell 1.35% ahead of the data. TSMC uses ASML's advanced lithography machines and will report Q3 earnings next week.